AS

Alain Sainsot

Europe, Midi-Pyrenees, France, Toulouse

Description

Alain Sainsot is the current President and Chief Executive Officer of GTP Bioways. He previously worked at AMATSIGROUP as a President. Alain...

Investor Profile

Alain Sainsot has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Private Equity rounds (top funding stages).
  • Majority of deals are located in France.
  • Strong thematic focus on Biotechnology, Health Care, Medical.

Stage Focus

  • Private Equity (100%)

Country Focus

  • France (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Alain Sainsot frequently co-invest with?

Galia Gestion
Europe, Aquitaine, France, Bordeaux
Co-Investments: 1
Auriga Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 1

Which angels does Alain Sainsot often collaborate with?

Shared Deals: 1

What are some of recent deals done by Alain Sainsot?

Flash Therapeutics

Toulouse, Midi-Pyrenees, France

Flash Therapeutics is a new gene therapy company developing gene and cell-based therapies by leveraging its proprietary lentiviral platform.

BiotechnologyHealth CareMedical
Private EquityMay 16, 2018
Amount Raised: $3,898,889